Breast Imaging

A cancer diagnosis can be terrifying news. Azela’s story is one that emphasizes the importance of both genetic cancer testing and family ties.

Amie Lee, MD was an invited speaker at a breast cancer awareness event to discuss the emotional and mental health needs of women with breast cancer in the Bay Area.

Radiomics is an emerging discipline in radiology. Researchers set out to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization of breast cancer phenotype and prognosis.

A new study by researchers at UC San Francisco looked at follow-up imaging for women with non-metastatic breast cancer across the country.

Collaborative efforts such as our event, 'Considering BRCA Genes: Knowledge Improves Outcomes,’ provide valuable insights on diagnosing and treating hereditary cancers.

During National Minority Health Month, research has pointed to a call to consider risk factors such as race and ethnicity when adjusting age-based breast cancer screening guidelines.

Whether you know your BRCA status or need to learn more, taking the time to listen to this informative panel discussion by global experts on BRCA mutations and breast cancer will help you understand genetic risks and how they affect health outcomes.

Last month, community members, researchers and providers from around the Bay Area came together for an important event on hereditary breast cancer and the rapid advances in research, coordinated teamwork, and the continuum of care offered at UCSF.

We’re proud to join the UCSF Helen Diller Family Comprehensive Cancer Center to open the dialogue about the vital importance of understanding genetic risks associated with BRCA gene mutations and how they affect health outcomes. On Tuesday, Oct. 24, the world’s leading experts who are changing the BRCA landscape in the Bay Area and beyond will come together with patients, referring physicians and community members for Considering BRCA Genes: Knowledge Improves Outcomes.

UCSF Radiology recommends annual mammograms to screen for breast cancer beginning at age 40. But at what age should women stop getting the exam? That question was the focus of a study authored by Dr. Cindy Lee, an assistant professor at the University of California San Francisco Department of Radiology and Biomedical Imaging.